Developing a first-in-class small molecule drug for inflammatory disease
European Pharmaceutical Review
NOVEMBER 9, 2023
TNF-alpha is an immune modulating cytokine whose dysregulation can lead to prolonged inflammatory responses and is known to drive disease in a range of autoimmune and inflammatory disorders. MYMD-1 has shown effectiveness in pre-clinical and clinical studies in regulating the immune system.
Let's personalize your content